3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
122
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Recurrence
18
Burkitt Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms, Plasma Cell
7
Neoplasms
7
Immunoglobulin Light-chain Amyloidosis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma
6
Leukemia, Biphenotypic, Acute
6
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Lymphoma, B-Cell
4
Lung Neoplasms
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Nausea
3
Colorectal Neoplasms
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Paraproteinemias
2
Ovarian Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Interventions
X-Rays
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
tazemetostat
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Topotecan
2
Nivolumab
2
Methotrexate
2
LY3023414
2
Etoposide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Dexamethasone
×
90 days
×
Clear all
No trials found.